Vascular Endothelial Growth Factor/Vascular Permeability Factor in the Pathogenesis of Primary Effusion Lymphomas

References

• Dvorak H. F., Nagy J. A., Feng D., Brown L. F., Dvorak A. M. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 1999; 237: 97–132
   PubMed Web of Science ®Google Scholar
• Luo J. C., Toyoda M., Shibuya M. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody. Cancer Res 1998; 58: 2594–2600
   PubMed Web of Science ®Google Scholar
• Knowles D. M., Inghirami G., Ubriaco A., Dalla-Favera R. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood 1989; 73: 792–799
   PubMed Web of Science ®Google Scholar
• Aoki Y., Tosato G. Role of Vascular Endothelial Growth Factor/Vascular Permeability Factor in the Pathogenesis of Kaposi's Sarcoma-Associated Herpesvirus-Infected Primary Effusion Lymphomas. Blood 1999; 94: 4241–4254
   Google Scholar
• Levine A. M. Acquired immunodeficiency syndrome-related lymphoma. Blood 1992; 80: 8–20
   PubMed Web of Science ®Google Scholar
• Schulz T. F., Boshoff C. H., Weiss R. A. HIV infection and neoplasia. Lancet 1996; 348: 587–591
   PubMed Web of Science ®Google Scholar
• Gaidano G., Carbone A., Dalla-Favera R. Genetic basis of acquired immunodeficiency syndrome-related lymphomagenesis. J Natl Cancer Inst Monogr 1998; 23: 95–100
   PubMedGoogle Scholar
• Ansari M. Q., Dawson D. B., Nador R., Rutherford C., Schneider N. R., Latimer M. J., Picker L., Knowles D. M., McKenna R. W. Primary body cuvity-basedAIDS-related lymphomas. Am J Clin Pathol 1996; 105: 221–229
   PubMed Web of Science ®Google Scholar
• Knowles D. M. Immunodeficiency-associated lymphoproliferative disorders. Mod Pathol 1999; 12: 200–217
   PubMed Web of Science ®Google Scholar
• Nador R. G., Cesarman E., Chadburn A., Dawson D. B., Ansari M. Q., Sald J., Knowles D. M. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996; 88: 645–656
   PubMed Web of Science ®Google Scholar
• Boshoff C., Gao S. J., Healy L. E., Matthews S., Thomas A. J., Coignet L., Warnke R. A., Strauchen J. A., Matutes E., Kamel O. W., Moore P. S., Weiss R. A., Chang Y. Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood 1998; 91: 1671–1679
   PubMed Web of Science ®Google Scholar
• Gaidano G., Gloghini A., Gattei V., Rossi M. F., Cilia A. M., Godeas C., Degan M., Perin T., Canzonieri V., Aldinucci D., Saglio G., Carbone A., Pinto A. Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen. Blood 1997; 90: 4894–4900
   PubMed Web of Science ®Google Scholar
• Carbone A., Gaidano G., Gloghini A., Larocca L. M., Capello D., Canzonieri V., Antinori A., Tirelli U., Falini B., Dalla-Favera R. Differential expression of BCL-6, CD138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non- Hodgkin's lymphomas. Blood 1998; 91: 747–755
   PubMed Web of Science ®Google Scholar
• Cesarman E., Chang Y., Moore P. S., Said J. W., Knowles D. M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS- related body-cavity-based lymphomas. N Engl J Med 1995; 332: 1186–1191
   PubMed Web of Science ®Google Scholar
• Schulz T. F. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). J Gen Virol 1998; 79: 1573–1591
   PubMed Web of Science ®Google Scholar
• Aoki Y., Jones K. D., Tosato G. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. J Hematother Stem Cell Res 2000; 9: 137–145
   PubMedGoogle Scholar
• Aoki Y., Jaffe E. S., Chang Y., Jones K., Teruya-Feldstein J., Moore P. S., Tosato G. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 1999; 93: 4034–4043
   PubMed Web of Science ®Google Scholar
• Staskus K. A., Sun R., Miller G., Racz P., Jaslowski A., Metroka C., Brett-Smith H., Haase A. T. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J Virol 1999; 73: 4181–4187
   PubMed Web of Science ®Google Scholar
• Jones K. D., Aoki Y., Chang Y., Moore P. S., Yarchoan R., Tosato G. Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood 1999; 94: 2871–2879
   PubMed Web of Science ®Google Scholar
• Aoki Y., Yarchoan R., Braun J., Iwamoto A., Tosato G. Viral and Cellular Cytokines in AIDS-related Malignant Lymphomatous Effusions. Blood 2000; 96: 1599–1601
   PubMed Web of Science ®Google Scholar
• Ferrara N. Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol 1999; 237: 1–30
   PubMed Web of Science ®Google Scholar
• Murohara T., Horowitz J. R., Silver M., Tsurumi Y., Chen D., Sullivan A., Isner J. M. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 1998; 97: 99–107
   PubMed Web of Science ®Google Scholar
• Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27–31
   PubMed Web of Science ®Google Scholar
• Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380: 435–439
   PubMed Web of Science ®Google Scholar
• Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K. S., Powell-Braxton L., Hillan K. J., Moore M. W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380: 439–442
   PubMed Web of Science ®Google Scholar
• Ferrara N., Winer J., Burton T., Rowland A., Siegel M., Phillips H. S., Terrell T., Keller G. A., Levinson A. D. Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. J Clin Invest 1993; 91: 160–170
   PubMed Web of Science ®Google Scholar
• Senger D. R., Galli S. J., Dvorak A. M., Perruzzi C. A., Harvey V. S., Dvorak H. F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219: 983–985
   PubMed Web of Science ®Google Scholar
• Shibuya M. Role of VEGF-flt receptor system in normal and tumor angiogenesis. Adv Cancer Res 1995; 67: 281–316
   PubMed Web of Science ®Google Scholar
• Mesiano S., Ferrara N., Jaffe R. B. Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization. Am. J Pathol 1998; 153: 1249–1256
   PubMed Web of Science ®Google Scholar
• Luo J. C., Yamaguchi S., Shinkai A., Shitara K., Shibuya M. Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors. Cancer Res 1998; 58: 2652–2660
   PubMed Web of Science ®Google Scholar
• Zebrowski B. K., Liu W., Ramirez K., Akagi Y., Mills G. B., Ellis L. M. Markedly elevated levels of vascular endothelial growth factor in malignant ascites. Ann Surg Oncol 1999; 6: 373–378
   PubMed Web of Science ®Google Scholar
• Aoki Y., Tosato G., Nambu Y., Iwamoto A., Yarchoan R. Detection of vascular endothelial growth factor in AIDS-related primary effusion lymphomas. Blood 2000; 95: 1109–1110
   PubMed Web of Science ®Google Scholar
• Angiolillo A. L., Sgadari C., Tosato G. A role for the interferon-inducible protein 10 in inhibition of angiogenesis by interleukin-12. Ann N Y Acad Sci 1996; 795: 158–167
   PubMed Web of Science ®Google Scholar
• Poltorak Z., Cohen T., Sivan R., Kandelis Y., Spira G., Vlodavsky I., Keshet E., Neufeld G. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem 1997; 272: 7151–7158
   PubMed Web of Science ®Google Scholar
• Clauss M., Weich H., Breier G., Knies U., Rockl W., Waltenberger J., Risau W. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 1996; 271: 17629–17634
   PubMed Web of Science ®Google Scholar
• Fong G. H., Rossant J., Gertsenstein M., Breitman M. L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995; 376: 66–70
   PubMed Web of Science ®Google Scholar
• Hiratsuka S., Minowa O., Kuno J., Noda T., Shibuya M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci USA 1998; 95: 9349–9354
   PubMed Web of Science ®Google Scholar
• Said W., Chien K., Takeuchi S., Tasaka T., Asou H., Cho S. K., de Vos S., Cesarman E., Knowles D. M., Koeffler H. P. Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: ultrastructural demonstration of herpesvirus in lymphoma cells. Blood 1996; 87: 4937–4943
   PubMed Web of Science ®Google Scholar
• Komanduri K. V., Luce J. A., McGrath M. S., Herndier B. G., Ng V. L. The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13: 215–226
   PubMedGoogle Scholar